Exact Sciences (NASDAQ: EXAS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Exact Sciences (NASDAQ: EXAS) through any online brokerage.
The latest price target for Exact Sciences (NASDAQ: EXAS) was reported by Craig-Hallum on Wednesday, August 3, 2022. The analyst firm set a price target for 60.00 expecting EXAS to rise to within 12 months (a possible 26.32% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Exact Sciences (NASDAQ: EXAS) is $47.5 last updated Today at August 8, 2022, 2:19 PM UTC.
There are no upcoming dividends for Exact Sciences.
Exact Sciences’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Exact Sciences.
Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.